$15.24
-$0.20
(-1.30%)
Quote as of 1:01 PM EST on 02/15/12
Momenta Pharmaceuticals
NASDAQ:MNTA
|
$15.24
-$0.20
(-1.30%)
|
|
| Today's Open | $15.47 |
|---|---|
| Previous Close | $15.44 |
| Daily Range | $15.25 - $15.48 |
| 52-Week Range | $10.15 - $21.00 |
| Market Cap | $780.92M |
| P/E Ratio | 4.35 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 279,865 |
| Average Daily Volume | 1,309,526 |
| Current FY EPS | $0.06 |
MNTA Information
| Description |
|---|
| A biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
All Good Things Must Come to an End
5 of Last Week's Biggest Losers
The Week's Biggest Stock Laggards
US Court Stays Momenta Injunction Against Generic Lovenox
Momenta Pharmaceuticals - Aggressive Growth
Zacks Releases Four Powerful ''Buy'' Stocks: Momenta Pharmaceuticals, Lowe's Companies, Humana and E
Here's How Momenta Pharmaceuticals Is Making You So Much Cash
12 Stocks for 2012 - Investment Ideas
Late to the Party? Hedge Funds Don't Buy Into the Recent Rally
Momenta Pharmaceuticals in Spotlight as Interest in Biotech Copycats Rise
